ID   PDE10_RAT               Reviewed;         794 AA.
AC   Q9QYJ6; Q6S9E6; Q6S9E7; Q6S9E8; Q6S9E9; Q9QYJ5;
DT   16-DEC-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-JUL-2015, entry version 86.
DE   RecName: Full=cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A;
DE            EC=3.1.4.17;
DE            EC=3.1.4.35;
GN   Name=Pde10a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING,
RP   FUNCTION, SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME
RP   REGULATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=10583409; DOI=10.1046/j.1432-1327.1999.00963.x;
RA   Fujishige K., Kotera J., Omori K.;
RT   "Striatum- and testis-specific phosphodiesterase PDE10A isolation and
RT   characterization of a rat PDE10A.";
RL   Eur. J. Biochem. 266:1118-1127(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4; 5 AND 6), TISSUE
RP   SPECIFICITY, CATALYTIC ACTIVITY, AND INDUCTION.
RC   STRAIN=Wistar;
RX   PubMed=14752115; DOI=10.1074/jbc.M312500200;
RA   O'Connor V., Genin A., Davis S., Karishma K.K., Doyere V.,
RA   De Zeeuw C.I., Sanger G., Hunt S.P., Richter-Levin G., Mallet J.,
RA   Laroche S., Bliss T.V.P., French P.J.;
RT   "Differential amplification of intron-containing transcripts reveals
RT   long term potentiation-associated up-regulation of specific Pde10A
RT   phosphodiesterase splice variants.";
RL   J. Biol. Chem. 279:15841-15849(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 452-794 IN COMPLEXES WITH
RP   ZINC; MAGNESIUM AND A SYNTHETIC INHIBITOR.
RX   PubMed=17228859; DOI=10.1021/jm060653b;
RA   Chappie T.A., Humphrey J.M., Allen M.P., Estep K.G., Fox C.B.,
RA   Lebel L.A., Liras S., Marr E.S., Menniti F.S., Pandit J.,
RA   Schmidt C.J., Tu M., Williams R.D., Yang F.V.;
RT   "Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A
RT   inhibitors.";
RL   J. Med. Chem. 50:182-185(2007).
CC   -!- FUNCTION: Plays a role in signal transduction by regulating the
CC       intracellular concentration of cyclic nucleotides. Can hydrolyze
CC       both cAMP and cGMP, but has higher affinity for cAMP and is more
CC       efficient with cAMP as substrate. {ECO:0000269|PubMed:10583409}.
CC   -!- CATALYTIC ACTIVITY: Nucleoside 3',5'-cyclic phosphate + H(2)O =
CC       nucleoside 5'-phosphate. {ECO:0000269|PubMed:14752115}.
CC   -!- CATALYTIC ACTIVITY: Guanosine 3',5'-cyclic phosphate + H(2)O =
CC       guanosine 5'-phosphate. {ECO:0000269|PubMed:14752115}.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions.;
CC   -!- ENZYME REGULATION: Inhibited by dipyridamole and moderately by
CC       IBMX, zaprinast and rolipram. {ECO:0000269|PubMed:10583409}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.26 uM for cAMP {ECO:0000269|PubMed:10583409};
CC         KM=9.3 uM for cGMP {ECO:0000269|PubMed:10583409};
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic AMP degradation; AMP from
CC       3',5'-cyclic AMP: step 1/1.
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from
CC       3',5'-cyclic GMP: step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10583409}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=PDE10A2;
CC         IsoId=Q9QYJ6-1; Sequence=Displayed;
CC       Name=2; Synonyms=PDE10A3;
CC         IsoId=Q9QYJ6-2; Sequence=VSP_035921;
CC       Name=3; Synonyms=PDE10A11;
CC         IsoId=Q9QYJ6-3; Sequence=VSP_035922;
CC       Name=4; Synonyms=PDE10A12;
CC         IsoId=Q9QYJ6-4; Sequence=VSP_035923;
CC       Name=5; Synonyms=PDE10A13;
CC         IsoId=Q9QYJ6-5; Sequence=VSP_035920;
CC       Name=6; Synonyms=PDE10A14;
CC         IsoId=Q9QYJ6-6; Sequence=VSP_035919;
CC   -!- TISSUE SPECIFICITY: Detected in striatum and testis (at protein
CC       level). Detected in whole brain, hippocampus, olfactory bulb,
CC       striatum neurons and testis. {ECO:0000269|PubMed:10583409,
CC       ECO:0000269|PubMed:14752115}.
CC   -!- INDUCTION: Up-regulated in brain after seizures. Up-regulated in
CC       the hippocampus one hour after induction of long-term
CC       potentiation. {ECO:0000269|PubMed:14752115}.
CC   -!- DOMAIN: The tandem GAF domains bind cAMP, and regulate enzyme
CC       activity. The binding of cAMP stimulates enzyme activity.
CC   -!- DOMAIN: Composed of a C-terminal catalytic domain containing two
CC       divalent metal sites and an N-terminal regulatory domain which
CC       contains one cyclic nucleotide-binding region.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB027155; BAA88996.1; -; mRNA.
DR   EMBL; AB027156; BAA88997.1; -; mRNA.
DR   EMBL; AY462091; AAS21243.1; -; mRNA.
DR   EMBL; AY462092; AAS21244.1; -; mRNA.
DR   EMBL; AY462093; AAS21245.1; -; mRNA.
DR   EMBL; AY462094; AAS21246.1; -; mRNA.
DR   EMBL; AY462095; AAS21247.1; -; mRNA.
DR   EMBL; CH474059; EDL83106.1; -; Genomic_DNA.
DR   RefSeq; NP_071572.1; NM_022236.1. [Q9QYJ6-1]
DR   UniGene; Rn.44869; -.
DR   PDB; 2O8H; X-ray; 1.80 A; A=452-794.
DR   PDB; 2OVV; X-ray; 2.00 A; A=452-794.
DR   PDB; 2OVY; X-ray; 1.80 A; A=452-794.
DR   PDB; 3HQW; X-ray; 1.70 A; A=452-794.
DR   PDB; 3HQY; X-ray; 2.00 A; A=452-794.
DR   PDB; 3HQZ; X-ray; 1.70 A; A=452-794.
DR   PDB; 3HR1; X-ray; 1.53 A; A=452-794.
DR   PDB; 3LXG; X-ray; 2.30 A; A=463-770.
DR   PDB; 3QPN; X-ray; 2.00 A; A=452-794.
DR   PDB; 3QPO; X-ray; 1.80 A; A=452-794.
DR   PDB; 3QPP; X-ray; 1.80 A; A=452-794.
DR   PDBsum; 2O8H; -.
DR   PDBsum; 2OVV; -.
DR   PDBsum; 2OVY; -.
DR   PDBsum; 3HQW; -.
DR   PDBsum; 3HQY; -.
DR   PDBsum; 3HQZ; -.
DR   PDBsum; 3HR1; -.
DR   PDBsum; 3LXG; -.
DR   PDBsum; 3QPN; -.
DR   PDBsum; 3QPO; -.
DR   PDBsum; 3QPP; -.
DR   ProteinModelPortal; Q9QYJ6; -.
DR   SMR; Q9QYJ6; 256-432, 464-770.
DR   STRING; 10116.ENSRNOP00000060834; -.
DR   BindingDB; Q9QYJ6; -.
DR   ChEMBL; CHEMBL6140; -.
DR   PaxDb; Q9QYJ6; -.
DR   PRIDE; Q9QYJ6; -.
DR   Ensembl; ENSRNOT00000043474; ENSRNOP00000042134; ENSRNOG00000011310. [Q9QYJ6-1]
DR   GeneID; 63885; -.
DR   KEGG; rno:63885; -.
DR   CTD; 10846; -.
DR   RGD; 68434; Pde10a.
DR   eggNOG; NOG270709; -.
DR   GeneTree; ENSGT00760000119066; -.
DR   HOGENOM; HOG000007068; -.
DR   HOVERGEN; HBG082113; -.
DR   InParanoid; Q9QYJ6; -.
DR   KO; K18438; -.
DR   TreeFam; TF316499; -.
DR   Reactome; REACT_287445; G alpha (s) signalling events.
DR   Reactome; REACT_349609; cGMP effects.
DR   UniPathway; UPA00762; UER00747.
DR   UniPathway; UPA00763; UER00748.
DR   EvolutionaryTrace; Q9QYJ6; -.
DR   NextBio; 612518; -.
DR   PMAP-CutDB; Q9QYJ6; -.
DR   PRO; PR:Q9QYJ6; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   ExpressionAtlas; Q9QYJ6; baseline.
DR   Genevisible; Q9QYJ6; RN.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030552; F:cAMP binding; IDA:RGD.
DR   GO; GO:0030553; F:cGMP binding; IDA:RGD.
DR   GO; GO:0004118; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; ISS:UniProtKB.
DR   GO; GO:0004112; F:cyclic-nucleotide phosphodiesterase activity; IDA:RGD.
DR   GO; GO:0008144; F:drug binding; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006198; P:cAMP catabolic process; IDA:RGD.
DR   GO; GO:0046069; P:cGMP catabolic process; IDA:RGD.
DR   GO; GO:0043949; P:regulation of cAMP-mediated signaling; IEA:Ensembl.
DR   GO; GO:0010738; P:regulation of protein kinase A signaling; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   Gene3D; 3.30.450.40; -; 2.
DR   InterPro; IPR003018; GAF.
DR   InterPro; IPR029016; GAF_dom-like.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF01590; GAF; 2.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00065; GAF; 2.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF55781; SSF55781; 2.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Alternative splicing; cAMP;
KW   cAMP-binding; cGMP; cGMP-binding; Complete proteome; Cytoplasm;
KW   Hydrolase; Metal-binding; Nucleotide-binding; Reference proteome;
KW   Repeat.
FT   CHAIN         1    794       cAMP and cAMP-inhibited cGMP 3',5'-cyclic
FT                                phosphodiesterase 10A.
FT                                /FTId=PRO_0000355559.
FT   REGION      296    297       Allosteric effector binding.
FT                                {ECO:0000250}.
FT   REGION      340    341       Allosteric effector binding.
FT                                {ECO:0000250}.
FT   ACT_SITE    525    525       Proton donor. {ECO:0000250}.
FT   METAL       529    529       Divalent metal cation 1.
FT   METAL       563    563       Divalent metal cation 1.
FT   METAL       564    564       Divalent metal cation 1.
FT   METAL       564    564       Divalent metal cation 2.
FT   METAL       674    674       Divalent metal cation 1.
FT   BINDING     374    374       Allosteric effector. {ECO:0000250}.
FT   BINDING     393    393       Allosteric effector. {ECO:0000250}.
FT   BINDING     525    525       Substrate. {ECO:0000250}.
FT   BINDING     726    726       Substrate. {ECO:0000250}.
FT   VAR_SEQ       1    141       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14752115}.
FT                                /FTId=VSP_035919.
FT   VAR_SEQ       1     80       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14752115}.
FT                                /FTId=VSP_035920.
FT   VAR_SEQ       1     23       MEDGPSNNASCFRRLTECFLSPS -> MSNDSPEGAVGSCN
FT                                ATG (in isoform 2).
FT                                {ECO:0000303|PubMed:10583409,
FT                                ECO:0000303|PubMed:14752115}.
FT                                /FTId=VSP_035921.
FT   VAR_SEQ       1     23       MEDGPSNNASCFRRLTECFLSPS -> MSKKRKALEGGGGG
FT                                GEPQLPEEEPTAWFGGSSEEPAGCLPITFKGGSKGPALLAL
FT                                RNRTDSRGQMSNDSPEGAVGSCNATG (in isoform
FT                                3). {ECO:0000303|PubMed:14752115}.
FT                                /FTId=VSP_035922.
FT   VAR_SEQ       1     23       MEDGPSNNASCFRRLTECFLSPS -> MSKKRKALEGGGGG
FT                                GEPQLPEEEPTAWFGGSSEEPAGCLPITFKGGSKGPALLAL
FT                                RNRTDSRGQMSNDSPEGAVGSCNATGSTGSTGELGKEFHTP
FT                                PRRKSASDSRLALCMG (in isoform 4).
FT                                {ECO:0000303|PubMed:14752115}.
FT                                /FTId=VSP_035923.
FT   HELIX       466    471       {ECO:0000244|PDB:3HR1}.
FT   HELIX       483    485       {ECO:0000244|PDB:3HR1}.
FT   HELIX       486    498       {ECO:0000244|PDB:3HR1}.
FT   HELIX       500    502       {ECO:0000244|PDB:3HQW}.
FT   HELIX       505    517       {ECO:0000244|PDB:3HR1}.
FT   STRAND      523    526       {ECO:0000244|PDB:3HR1}.
FT   HELIX       527    542       {ECO:0000244|PDB:3HR1}.
FT   TURN        545    547       {ECO:0000244|PDB:3HR1}.
FT   HELIX       550    562       {ECO:0000244|PDB:3HR1}.
FT   TURN        563    566       {ECO:0000244|PDB:3HR1}.
FT   HELIX       572    578       {ECO:0000244|PDB:3HR1}.
FT   HELIX       581    585       {ECO:0000244|PDB:3HR1}.
FT   STRAND      587    589       {ECO:0000244|PDB:3HR1}.
FT   HELIX       590    603       {ECO:0000244|PDB:3HR1}.
FT   TURN        610    613       {ECO:0000244|PDB:3HR1}.
FT   HELIX       616    632       {ECO:0000244|PDB:3HR1}.
FT   HELIX       635    650       {ECO:0000244|PDB:3HR1}.
FT   HELIX       659    674       {ECO:0000244|PDB:3HR1}.
FT   HELIX       676    679       {ECO:0000244|PDB:3HR1}.
FT   HELIX       682    705       {ECO:0000244|PDB:3HR1}.
FT   HELIX       712    714       {ECO:0000244|PDB:3HR1}.
FT   HELIX       716    721       {ECO:0000244|PDB:3HR1}.
FT   HELIX       722    732       {ECO:0000244|PDB:3HR1}.
FT   HELIX       734    744       {ECO:0000244|PDB:3HR1}.
FT   HELIX       746    748       {ECO:0000244|PDB:3HR1}.
FT   HELIX       749    766       {ECO:0000244|PDB:3HR1}.
SQ   SEQUENCE   794 AA;  90161 MW;  A36C4678B385846E CRC64;
     MEDGPSNNAS CFRRLTECFL SPSLTDEKVK AYLSLHPQVL DEFVSESVSA ETVEKWLKRK
     NNKAEDEPSP KEVSRYQDTN MQGVVYELNS YIEQRLDTGG DNHLLLYELS SIIRIATKAD
     GFALYFLGEC NNSLCVFTPP GMKEGQPRLI PAGPITQGTT ISAYVAKSRK TLLVEDILGD
     ERFPRGTGLE SGTRIQSVLC LPIVTAIGDL IGILELYRHW GKEAFCLSHQ EVATANLAWA
     SVAIHQVQVC RGLAKQTELN DFLLDVSKTY FDNIVAIDSL LEHIMIYAKN LVNADRCALF
     QVDHKNKELY SDLFDIGEEK EGKPVFKKTK EIRFSIEKGI AGQVARTGEV LNIPDAYADP
     RFNREVDLYT GYTTRNILCM PIVSRGSVIG VVQMVNKISG SAFSKTDENN FKMFAVFCAL
     ALHCANMYHR IRHSECIYRV TMEKLSYHSI CTSEEWQGLM HFNLPARICR DIELFHFDIG
     PFENMWPGIF VYMIHRSCGT SCFELEKLCR FIMSVKKNYR RVPYHNWKHA VTVAHCMYAI
     LQNNNGLFTD LERKGLLIAC LCHDLDHRGF SNSYLQKFDH PLAALYSTST MEQHHFSQTV
     SILQLEGHNI FSTLSSSEYE QVLEIIRKAI IATDLALYFG NRKQLEEMYQ TGSLNLHNQS
     HRDRVIGLMM TACDLCSVTK LWPVTKLTAN DIYAEFWAEG DEMKKLGIQP IPMMDRDKRD
     EVPQGQLGFY NAVAIPCYTT LTQILPPTEP LLKACRDNLN QWEKVIRGEE TAMWISGPAT
     SKSTSEKPTR KVDD
//
